Top 5 Life Science Angel Investors in Canada in January 2026
Top 5 Life Science Angel Investors in Canada in January 2026
| Investor | Life Science Canada investments |
|---|---|
| Balaji Srinivasan | 2 |
| Jed McCaleb | 1 |
| Dan Schultz | 1 |
| Rami Essaid | 1 |
| Joe Betts-Lacroix | 1 |
Reach every investor
Get a list of investors who already back your industry, stage, and country. Emails & phones included.
Find investors — It's Free!Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. He was previously CEO at Earn.com, which was recently sold to Coinbase. Prior to taking the CEO role at Earn.com, Dr. Srinivasan was a General Partner at Andreessen Horowitz. Prior to joininga16z, he was the co-founder and CTO of Founders Fund-backed Counsyl, where he won the Wall Street Journal Innovation Award for Medicine and was named to the MIT TR35. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including an online MOOC in 2013 which reached 250,000+ students worldwide.
Show more...Investment focus
- Blockchain, Cryptocurrency, Software
- Seed, Pre-Seed, Series A
- United States, India, Singapore
Portfolio highlights
- Blitz Electric Mobility — Blitz provides electric vehicles and fleet management software to food and beverage delivery, courier, and logistics companies.
- Paradigm — The AI-powered way to do spreadsheet work. Set up, edit, populate, and analyze sheets with assistant. Enrich empty cells with data from trusted sources.
- Inversion — Inversion is a technology-first investment company that acquires and transforms legacy businesses with blockchain technology.
Jed McCaleb is based out of San Francisco, California and is the Founder of Vast. Jed previously worked at Ripple as a Co-Founder.
Show more...Investment focus
- Internet, Payments, SaaS
- Seed, Series A, Initial Coin Offering
- United States, Canada
Portfolio highlights
- Bold Financial Technologies — Bold Financial Technologies is a payment and compliance operations for on-demand service operators. It's payouts stack to pay new publishers globally offers a REST API integration, from background checks to driving record screening and local currency payouts; and provides Bold Payouts platform, a solution for marketplaces to leverage a singleintegration that offers a back-office payout infrastructure.Bold Financial Technologies streamlines the process of mass payouts while exponentially growing the international reach of its clients. It also provides a complete administrative platform, including Tax tracking and reporting, recipient onboarding, a client administrative portal, a recipient portal, and an API.It was founded in 2014 and is headquartered in San Francisco, California.
- Stream Token — Stream is a new decentralized blockchain-based token that allows livestreamers to easily and anonymously accept payments from their audience members anywhere in the world, with extremely low transaction fees and no platform lock-in.
- Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.
Dan Schultz
Show more...Investment focus
- SaaS, Data Mining, Life Science
- Seed
- Canada, United States
Portfolio highlights
- Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
- Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.
Rami Essaid is the Co-Founder and Chief Executive Officer of Finmark, a Venture Partner at IDEA Fund Partners, and an Extended Team Member of Ubiquity Ventures. He was the Co-Founder and Chairman of Distil. Rami helps enterprises embrace the cloud to improve their scalability and reliability while maintaining a high level of security.He attendedNorth Carolina State University where he majored in computer engineering.
Show more...Investment focus
- SaaS, Data Mining, Life Science
- Seed
- Canada, United States
Portfolio highlights
- Kontigo — We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app.
- Prospectify — #1 trusted site to buy youtube subscribers India. Offer high quality, safe and legit buy youtube subscribers cheap prices and order starts in 24-48 Hrs
- Propellon Therapeutics — Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The overexpression of WDR5 and resulting deregulation of epigenetic mechanisms are implicated in various cancers and correlated with poor patient survival.Established by FACIT, Propellon’s WDR5 inhibitor platform arises from discoveries, research and innovations originating from OICR.
Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
Show more...Investment focus
- Life Science, Biotechnology, Pharmaceutical
- Seed
- United States
Portfolio highlights
- VitaDAO — Join VitaDAO, a community owned collective funding early stage longevity research. We fund and commercialize longevity therapeutics.
- Spring Discovery — Giving Scientists AI Superpowers
Contact investors today
Find who invests in your industry, stage, and country in 5 minutes.
Find investors — It's Free!